Team VIVA!
February is Ovarian Cancer Awareness Month
Ovarian cancer is the deadliest women’s cancer. Each day, four Australian women are diagnosed with ovarian cancer and each day, it claims the lives of three women. This February is Ovarian Cancer Awareness Month and Ovarian Cancer Australia (OCA) says it’s time to ovary-act. There is an urgent need to improve survival rates and increase ovarian…
Read MoreFormer NRL Player, Dan Hunt reinforces the importance of living a purposeful life to Team VIVA!
At our recent annual workshop staged at Lilianfels Resort & Spa, Blue Mountains, NSW between 17-18 January, 2019, we reflected on our PR agency’s achievements over the past year and discussed strategies to enable us to move forward in 2019. During our workshop, former NRL star and guest speaker, Dan Hunt, 32, took us on…
Read MoreThe do’s and don’ts of office productivity
Do embrace a collaborative and diverse workplace culture Organisations that succeed display strength of combined diverse expertise by harnessing each team member’s strength to boost productivity. Let everyone’s true colours shine. Let the creatives be creative and lets the nerds be the nerds. If everyone had the exact same skill set, the potential output of…
Read MoreResearchers uncover the effects of aroma on making food selections
An American research team have uncovered the effect of aroma when people make the selection between healthy and unhealthy food. Researchers from the marketing department at the University of South Florida in Tampa set out to understand how food-related ambient scents affected food choices. The team found people exposed to an unhealthy food aroma for…
Read MoreFederal Health Minister announces Feb 1 PBS listing of psoriasis biologic, ILUMYA
A targeted biologic for the estimated 19,000 Australian adults living with severe chronic plaque psoriasis will be listed on the PBS from February 1, 2019. Federal Health Minister, The Hon. Greg Hunt, MP, announced the PBS listing of Sun Pharma’s ILUMYA (tildrakizumab) today, for those who meet the reimbursement criteria. ILUMYA belongs to a new class…
Read More